{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T10:27:25Z","timestamp":1794479245068,"version":"4.9.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","award":["P30 CA054174"],"award-info":[{"award-number":["P30 CA054174"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.surg.2026.110234","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:38:22Z","timestamp":1778492302000},"page":"110234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Trends in perioperative systemic chemotherapy for resected colorectal liver metastases: A Surveillance, Epidemiology, and End Results\u2013Medicare analysis"],"prefix":"10.1016","volume":"196","author":[{"given":"Candice","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M.","family":"Court","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin A.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett L.","family":"Ecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110234_bib1","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO Consensus Guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110234_bib3","article-title":"Impact of comorbidity burden on clinical outcomes in older adults with metastatic colorectal cancer: a systematic review and meta-analysis","volume":"17","author":"Ohta","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/j.surg.2026.110234_bib4","first-page":"663","article-title":"Multimodal management of colorectal liver metastases: state of the art","volume":"17","author":"Filoni","year":"2023","journal-title":"Oncol Rev"},{"key":"10.1016\/j.surg.2026.110234_bib5","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i7.107438","article-title":"Current status and advances in the treatment of colorectal cancer with liver metastases","volume":"16","author":"Liu","year":"2025","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib6","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.surg.2018.01.004","article-title":"Actual 10-year survival after hepatic resection of colorectal liver metastases: what factors preclude cure?","volume":"163","author":"Creasy","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110234_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ejso.2020.07.030","article-title":"Impact of patient, primary tumor and metastatic pattern including tumor location on survival in patients undergoing ablation or resection for colorectal liver metastases","volume":"47","author":"Scherman","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.hpb.2016.03.001","article-title":"Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal liver metastases","volume":"18","author":"Khoo","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2026.110234_bib9","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1245\/s10434-020-08777-z","article-title":"The landmark series: randomized controlled trials examining perioperative chemotherapy and postoperative adjuvant chemotherapy for resectable colorectal liver metastasis","volume":"27","author":"Kawaguchi","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib10","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.3390\/cancers12123535","article-title":"Perioperative chemotherapy for liver metastasis of colorectal cancer","volume":"12","author":"Chan","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2026.110234_bib11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/SLA.0b013e3181b4539b","article-title":"Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis","volume":"250","author":"de Jong","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2026.110234_bib12","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1200\/JCO.2006.06.8353","article-title":"Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases","volume":"24","author":"Portier","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib13","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup Trial 40983): a randomized controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2026.110234_bib14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S1470-2045(13)70447-9","article-title":"Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomized, controlled, phase 3 trial","volume":"14","author":"Nordlinger","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib15","first-page":"254","article-title":"Adjuvant chemotherapy after resection of colorectal liver metastases: a randomized controlled trial","volume":"34","author":"Hasegawa","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1470-2045(14)70105-6","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the new EPOC randomized controlled trial","volume":"15","author":"Primrose","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1470-2045(19)30798-3","article-title":"Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (new EPOC): long-term results of a multicentre, randomized, controlled, phase 3 trial","volume":"21","author":"Bridgewater","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib18","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1200\/JCO.2011.41.1140","article-title":"Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years","volume":"30","author":"Sanoff","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib19","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1200\/JCO.2012.42.5645","article-title":"Adjuvant therapy with fluorouracil and oxaliplatin in stage II and elderly patients with colon cancer: subgroup analyses of the MOSAIC trial","volume":"30","author":"Tournigand","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib20","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.2011.36.4539","article-title":"Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial","volume":"29","author":"Yothers","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib21","series-title":"NCCN Clinical Practice Guidelines in Oncology: Colon Cancer. Version 4.2025","year":"2025"},{"key":"10.1016\/j.surg.2026.110234_bib22","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1097\/MLR.0b013e318289c3fb","article-title":"An evaluation of algorithms for identifying metastatic breast, lung, or colorectal cancer in administrative claims data","volume":"53","author":"Whyte","year":"2015","journal-title":"Med Care"},{"key":"10.1016\/j.surg.2026.110234_bib23","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1007\/s11605-013-2325-z","article-title":"Trends in the multimodality treatment of resectable colorectal liver metastases: an underutilized strategy","volume":"17","author":"Parikh","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.surg.2026.110234_bib24","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.21.01032","article-title":"Hepatectomy followed by mFOLFOX6 versus hepatectomy alone for liver-only metastatic colorectal cancer (JCOG0603): a phase II or III randomized controlled trial","volume":"39","author":"Kanemitsu","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib25","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/jnci\/djt318","article-title":"Racial disparity in consultation, treatment, and the impact on survival in metastatic colorectal cancer","volume":"105","author":"Simpson","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.surg.2026.110234_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.29563","article-title":"Hospital accreditation status and treatment differences among Black patients with colon cancer","volume":"7","author":"Chan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.surg.2026.110234_bib27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jso.28022","article-title":"The effect of health insurance on racial disparities in patients with isolated colorectal liver metastases","volume":"131","author":"Mitsakos","year":"2025","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/bjs5.50174","article-title":"Multicentre study of perioperative versus adjuvant chemotherapy for resectable colorectal liver metastases","volume":"3","author":"Allard","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/j.surg.2026.110234_bib29","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"26","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib30","first-page":"1234","article-title":"Adjuvant chemotherapy is associated with improved survival after resection of synchronous colorectal liver metastases: a nationwide population-based study","volume":"32","author":"Sternby Eilard","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2026.110234_bib31","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.hpb.2019.03.365","article-title":"Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer","volume":"21","author":"McCracken","year":"2019","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2026.110234_bib32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.21037\/hbsn-22-285","article-title":"Clinical and molecular heterogeneity associated with tumor sidedness in colorectal liver metastasis: a multicenter propensity cohort study","volume":"13","author":"Wu","year":"2023","journal-title":"Hepatobiliary Surg Nutr"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026001595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026001595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:36:50Z","timestamp":1794476210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026001595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":32,"alternative-id":["S0039606026001595"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110234","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in perioperative systemic chemotherapy for resected colorectal liver metastases: A Surveillance, Epidemiology, and End Results\u2013Medicare analysis","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110234"}}